You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Autologous Stem Cell Transplant

Showing 76 - 100 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsing Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in United

Recruiting
  • Relapsing Multiple Sclerosis
  • +2 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • Best Available Therapy (BAT)
  • Palo Alto, California
  • +20 more
Jan 25, 2023

Multiple Myeloma Trial in United States (procedure, drug, behavioral)

Completed
Has Results
  • Multiple Myeloma
  • One Autologous Transplant
  • +5 more
  • Birmingham, Alabama
  • +35 more
Oct 19, 2021

Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell Trial in China (Chidamide, Cladribine, Gemcitabine)

Recruiting
  • Lymphoma, Large B-Cell, Diffuse
  • Lymphoma, T-Cell
  • Deyang, Deyang, China
  • +10 more
Jul 21, 2022

Multiple Myeloma Trial in Canada (Busulfan, Melphalan, Lenalidomide)

Completed
  • Multiple Myeloma
  • Edmonton, Alberta, Canada
  • +9 more
Sep 20, 2022

Hodgkin Lymphoma, Adult, Relapsed Hodgkin's Disease, Adult, Refractory Hodgkin Lymphoma Trial in Caba (Evaluation of

Recruiting
  • Hodgkin Lymphoma, Adult
  • +2 more
  • Evaluation of therapeutical approach after ASCT
  • Caba, Argentina
    FUNDALEU
Oct 1, 2021

Hodgkin Disease, Hodgkin Lymphoma Trial run by the NCI (procedure, drug, radiation)

Terminated
Has Results
  • Hodgkin Disease
  • Hodgkin Lymphoma
  • Auto stem cell transplant
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 16, 2021

Hodgkin's Lymphoma Trial in Poland (drug, diagnostic test, procedure)

Recruiting
  • Hodgkin's Lymphoma
  • Bydgoszcz, Poland
  • +12 more
Dec 23, 2021

Autologous Hematopoietic Stem Cell Transplant Recipient, Loss of Chromosome 17p, Plasma Cell Leukemia Trial in Duarte (drug,

Active, not recruiting
  • Autologous Hematopoietic Stem Cell Transplant Recipient
  • +4 more
  • Duarte, California
    City of Hope
Mar 17, 2022

Multiple Myeloma Trial in United States (Plinabulin)

Recruiting
  • Multiple Myeloma
  • Basking Ridge, New Jersey
  • +6 more
Jun 17, 2022

Complication of Transplanted Organ, Nos Trial in Ottawa, Toronto (Autologous Hematopoietic Stem Cell Transplant)

Completed
  • Complication of Transplanted Organ, Nos
  • Autologous Hematopoietic Stem Cell Transplant
  • Ottawa, Ontario, Canada
  • +1 more
Apr 27, 2021

Multiple Myeloma Trial in United States (Iberdomide)

Recruiting
  • Multiple Myeloma
  • Basking Ridge, New Jersey
  • +7 more
Jun 10, 2022

Multiple Myeloma Trial in Worldwide (Daratumumab, Bortezomib, Lenalidomide)

Not yet recruiting
  • Multiple Myeloma
  • Adelaide, Australia
  • +51 more
Feb 16, 2022

Plasma Cell Myeloma Trial in Seattle (biological, drug, procedure)

Recruiting
  • Plasma Cell Myeloma
  • Astatine At 211 Anti-CD38 Monoclonal Antibody OKT10-B10
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 27, 2022

Myelodysplastic Syndrome, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Boston (biological, procedure, drug)

Terminated
Has Results
  • Myelodysplastic Syndrome
  • +2 more
  • GVAX
  • +6 more
  • Boston, Massachusetts
  • +3 more
Jun 30, 2022

Multiple Myeloma Trial in Baltimore (biological, drug, procedure)

Completed
Has Results
  • Multiple Myeloma
  • Activated marrow infiltrating lymphocytes
  • +6 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mar 16, 2021

Ganglioneuroblastoma, High Risk Neuroblastoma Trial in Australia, New Zealand, United States (procedure, drug, biological,

Active, not recruiting
  • Ganglioneuroblastoma
  • High Risk Neuroblastoma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +14 more
  • Los Angeles, California
  • +9 more
Sep 1, 2022

Mantle Cell Lymphoma, Recurrent DLBCL, Recurrent Follicular Lymphoma Trial in Houston (procedure, drug, biological)

Completed
  • Mantle Cell Lymphoma
  • +6 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 18, 2022

Diffuse Large B Cell Lymphoma Trial in Poland (Ofatumumab, Etoposide, Ifosfamid)

Completed
  • Diffuse Large B Cell Lymphoma
  • Wrocław, Dolnośląskie, Poland
  • +7 more
Dec 23, 2021

Recurrent Plasma Cell Myeloma Trial in Houston (Daratumumab)

Recruiting
  • Recurrent Plasma Cell Myeloma
  • Daratumumab
  • Houston, Texas
    M D Anderson Cancer Center
Dec 22, 2021

Multiple Myeloma and Plasma Cell Tumor, Neurotoxicity Trial in Duarte (drug, genetic, other, procedure)

Completed
Has Results
  • Multiple Myeloma and Plasma Cell Neoplasm
  • Neurotoxicity
  • Duarte, California
    City of Hope Medical Center
Aug 17, 2021

Blastic Plasmacytoid Dendritic Cell Tumor Trial in Houston (Tagraxofusp-erzs)

Active, not recruiting
  • Blastic Plasmacytoid Dendritic Cell Neoplasm
  • Tagraxofusp-erzs
  • Houston, Texas
    M D Anderson Cancer Center
Apr 8, 2022

Multiple Myeloma, Lymphoma Trial in Washington, Hackensack (Ipilimumab, Nivolumab)

Active, not recruiting
  • Multiple Myeloma
  • Lymphoma
  • Washington, District of Columbia
  • +1 more
Dec 2, 2021

Stem Cells Mobilization, colLection and Engraftment in Newly

Recruiting
  • Multiple Myeloma
  • +3 more
  • Rome, Italy
    Fondazione Policlinico Universitario A.Gemelli IRCCS
Apr 28, 2023

Ewing's Family Tumors, Renal Tumors, Hepatoblastoma Trial in Minneapolis (drug, biological, radiation, procedure)

Recruiting
  • Ewing's Family Tumors
  • +11 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Apr 11, 2022

Anaplastic Large Cell Lymphoma, ALK-Negative, Anaplastic Large Cell Lymphoma, ALK-Positive, Hepatosplenic T-Cell Lymphoma Trial

Completed
Has Results
  • Anaplastic Large Cell Lymphoma, ALK-Negative
  • +9 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +8 more
  • Duarte, California
  • +7 more
Nov 4, 2022